Farrell Michael J. reported option exercise involving 683 shares of RESMED INC at $146.34 for $100k on Nov 9, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chairman and CEO
Chairman and CEO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$99,950.22Shares × reported price
Shares traded
683ResMed Common Stock
Price per share
$146.34Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
480,486Direct
Trade date
Nov 9, 2026Option exercise
Filed
Nov 12, 2026, 6:04 AM ET3-day reporting delay
Accession
0000943819-26-000091Code M · Transaction 398155
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise4,310$146.34$630,725.40Trade 398156
Nov 9, 2026Sell4,993$235.35−$1,175,089.07Trade 398157
Nov 9, 2026Option exercise683$0.00$0Trade 398158
Nov 9, 2026Option exercise4,310$0.00$0Trade 398159
5 transaction rows in this filing. Joint filers share the same rows.

RMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −2.2%1w ago −1%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024. F2: This transaction was executed in multiple trades at prices ranging from $231.7956 - $237.600. The price reported above reflects the weighted average sale price. F3: Represents date options first become exercisable. Options vest 1/3 per year F4: Represents date options first become exercisable. Options vest 1/3 per year